The present invention is related to compositions containing netarsudil and low-dose brimonidine. The present invention is further related to methods of treating ophthalmological disease by administering compositions of the present invention. The present invention is further related to methods of increasing residency time of netarsudil on the surface of an eye by co-administering low-dose brimonidine.
